Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Doughty

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 24, 2007
Lanoteplase: a viewpoint by Robert Neil DoughtyR N Doughty
Heart Failure Monitor|March 14, 2003
beta-Blocker therapy in heart failureR N Doughty
European Journal of Heart Failure|August 10, 2000
Beta-blockers for advanced heart failure--how far can you go?R N Doughty
Drugs & Aging|May 1, 1996
Optimal treatment of angina in older patientsR N Doughty, N Sharpe
Journal of Cardiovascular Risk|August 27, 1999
Effects of beta-blockers on symptoms and exercise tolerance in patients with heart failureR N Doughty, N Sharpe
Annual Review of Medicine|January 1, 1997
Beta-adrenergic blocking agents in the treatment of congestive heart failure: mechanisms and clinical resultsR N Doughty, N Sharpe
European Heart Journal|August 23, 2002
Optimization of ACE inhibitor therapy in heart failureR N Doughty, N Sharpe
European Heart Journal|March 31, 1998
Left ventricular remodelling and improved long-term outcomes in chronic heart failureN Sharpe, R N Doughty
British Journal of Hospital Medicine|May 1, 1996
Current management of congestive heart failureR N Doughty, N Sharpe
The New Zealand Medical Journal|December 10, 1999
Measuring health-related quality of lifeS P Wright, R N Doughty
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 24, 2007
Lanoteplase: a viewpoint by Robert Neil DoughtyR N Doughty
Heart Failure Monitor|March 14, 2003
beta-Blocker therapy in heart failureR N Doughty
European Journal of Heart Failure|August 10, 2000
Beta-blockers for advanced heart failure--how far can you go?R N Doughty
Drugs & Aging|May 1, 1996
Optimal treatment of angina in older patientsR N Doughty, N Sharpe
Journal of Cardiovascular Risk|August 27, 1999
Effects of beta-blockers on symptoms and exercise tolerance in patients with heart failureR N Doughty, N Sharpe
Annual Review of Medicine|January 1, 1997
Beta-adrenergic blocking agents in the treatment of congestive heart failure: mechanisms and clinical resultsR N Doughty, N Sharpe
European Heart Journal|August 23, 2002
Optimization of ACE inhibitor therapy in heart failureR N Doughty, N Sharpe
European Heart Journal|March 31, 1998
Left ventricular remodelling and improved long-term outcomes in chronic heart failureN Sharpe, R N Doughty
British Journal of Hospital Medicine|May 1, 1996
Current management of congestive heart failureR N Doughty, N Sharpe
The New Zealand Medical Journal|December 10, 1999
Measuring health-related quality of lifeS P Wright, R N Doughty
Pageof 5